https://www.selleckchem.com/pr....oducts/sb290157-tfa.
interventions at an early stage and provides valuable insights for further feasibility testing. Patients with decompensated cirrhosis suffer from recurrent infections and inadequate responses to prophylactic vaccinations. However, many patients present with hypergammaglobulinemia (HGG), indicating a sustained ability to generate antibody responses. As follicular T helper (Tfh) cells are central facilitators of humoral immunity, we hypothesized that Tfh cell responses may be altered in advanced liver disease and we aimed to identify
Aimer
Commentaire
Partagez
